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Abstract
 
Splenectomized and asplenic patients have a high incidence of infections by encapsulated bacteria
and do not respond to polysaccharide vaccines. To understand whether the absence of the spleen is
associated with a defined B cell defect, we analyzed B cell subsets in the peripheral blood. We
found that a population of B cells known as immunoglobulin (Ig)M memory is lacking in patients
without spleen. The absence of IgM memory B cells correlates with an impaired immune response
to encapsulated bacteria not only in splenectomized patients, but also in individuals with an intact
spleen. We show that the physiological and transient predisposition to pneumococcal infections of
young children (0–2 yr) is associated with the lack of circulating IgM memory B cells and of serum
antipolysaccharide IgM. We also demonstrate that IgM memory B cells are undetectable in a frac-
tion of patients with common variable immunodeficiency, who have recurrent and invasive in-
fections by encapsulated bacteria. IgM memory B cells, therefore, require the spleen for their gen-
eration and/or survival and are responsible for the protection against encapsulated bacteria.
Key words: B cells • asplenia • polysaccharide vaccines • 
 
Streptococcus pneumoniae
 
 • infants 
 
Introduction
 
Patients with anatomical or functional asplenia suffer from
recurrent and invasive infections of the respiratory tract
caused by encapsulated bacteria (mostly 
 
Streptococcus pneu-
moniae
 
), which develop into overwhelming postsplenec-
tomy infections (OPSI) in 5% of the adults and 20% of the
children. OPSI is characterized by intravascular dissemi-
nated coagulation, septic shock, and multi-organ failure
and is lethal in 50% of the adults and in almost all of the
children (1). The incidence of congenital asplenia is very
low and most children born without spleen die of infection
during the first months of life (2). Vaccines containing bac-
terial capsular polysaccharides do not induce antibodies in
splenectomized patients (3).
Infections with 
 
S. pneumoniae
 
 kill one million children
each year worldwide (4). Before 2 yr of age, 
 
S. pneumoniae
 
causes 50% of otitis media and most of pneumonia and
meningitis. Polysaccharide vaccines are ineffective in in-
fants but protective in older children (5).
Recurrent infections by encapsulated bacteria are the
most common clinical manifestations in patients with com-
mon variable immunodeficiency (CVID), a heterogeneous
immune disorder of unknown pathogenesis characterized
by the inability to mount protective antibody responses in
the presence of normal numbers of circulating B cells. De-
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spite the profound hypogammaglobulinemia, a minority of
the patients are asymptomatic (6).
We analyzed B cell subsets in three groups of individuals
who have different medical conditions but share an in-
creased susceptibility to infections by encapsulated bacteria,
to answer the question of whether a high risk of infection is
associated with the absence of a defined B cell pool. We
found that in the absence of the spleen the so-called IgM
memory B cells are undetectable in the blood. IgM mem-
ory B cells are also lacking in infants and CVID patients.
IgM memory B cells, therefore, need the splenic mi-
croenvironment for their generation and/or survival and
are the B cell subset indispensable for the protection against
encapsulated bacteria in humans.
 
Materials and Methods
 
Subjects.
 
Splenectomized and asplenic patients and healthy do-
nors were recruited from the University Hospitals of Freiburg, Düs-
seldorf, Clermont-Ferrand, and from the Ospedale Pediatrico Bam-
bino Gesù in Rome. Blood from 39 healthy infants and CVID
patients was obtained from the University of Rome “La Sapienza”
and the University of Brescia. All samples were collected with pa-
rental or patients’ informed consent. The study protocol conforms to
the ethical guidelines of the 1975 Declaration of Helsinki as reflected
in a prior approval by the institution’s human research committee.
 
Flow Cytometry Analysis.
 
Mononuclear cells were stained
with the appropriate antibody combinations of fluorescein, phy-
coerythrin, APC, cychrome, or biotin-labeled antibodies fol-
lowed by streptavidin-cychrome and streptavidin-APC (Cal-
tag). Monoclonal antibodies UCHT2 (anti-CD5), HIB19 (anti-
CD19), HIB22 (anti-CD22), M-T271 (anti-CD27), G20-127
(anti-IgM), and IA6-2 (anti-IgD) were obtained from BD Bio-
sciences and anti-IgM Fc5
 
  
 
fragment specific was obtained from
Jackson ImmunoResearch Laboratories.
Dead cells were excluded from analysis by side/forward scatter
gating. All analyses were performed on a FACSCalibur
 
® 
 
(Becton
Dickinson) interfaced to a Macintosh CellQuest™ computer
program.
 
Polysaccharides and Sera.
 
Pneumococcal antigens, types 3, 9,
and 22, were obtained from the American Type Culture Collec-
tion and pneumococcal C polysaccharide was obtained from the
Statens Seruminstitut. Hyperimmune sera from blood donors im-
munized with pneumococcal vaccine was used to establish the
different polysaccharide serotype ELISAs. A standard serum from
a vaccinated adult was included in every ELISA. ELISA proce-
dures were previously described (7).
 
Results
 
B Cell Subsets in the Human Peripheral Blood.
 
Two pop-
ulations of B cells have been identified in human peripheral
blood: mature and memory B cells. These populations can
be distinguished by the combined use of CD22 and CD27.
CD22 is a B cell marker (8) and CD27 is expressed on
memory B and T cells (9). Mature B cells are CD27
 
  
 
and
Figure 1. (A) Phenotypic analysis of B cells in the human peripheral
blood. Donor PBLs were stained with Abs to CD22, CD27, IgM, and
IgD and analyzed by four-color flow cytometry. Data is presented as den-
sity plots. CD22  B cells were separated into CD27  memory B cells
(60%) and CD27  mature B cells (40%; left). In the right panels, IgD and
IgM staining of all cells in the lymphocyte gate and of mature and mem-
ory B cells, identified as indicated in the left panel, is shown. Mature B
cells are IgM  IgDbright. Two populations of memory B cells can be iden-
tified, IgMbright IgDdull IgM memory B cells and switched memory B cells
lacking the expression of both IgM and IgD. (B) Frequency of CD5  B
cells in the mature and memory compartments of eight donors. The ex-
pression of CD5 in IgM and switched memory B cells was calculated
based on the staining for CD22, CD27, IgM, and CD5.T
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circulating memory B cells are CD27
 
  
 
(Fig. 1 A, left).
Based on the relative expression of IgM and IgD, memory
B cells can be further subdivided into 
 
 
 
50% IgM memory
(IgM
 
bright 
 
IgD
 
dull
 
) and 50% switched memory B cells (IgM
 
 
 
IgD
 
 
 
; Fig. 1 A).
In the mouse the expression of CD5 identifies B-1a B
cells (10). In humans, CD5
 
  
 
B cells have also been de-
scribed. We found that CD5
 
  
 
cells represented a highly
variable but minor fraction of both mature (from 12 to 58%)
and memory B cell (4–19%) pools (Fig. 1 B). CD5, there-
fore, does not define a population of B cells in humans.
 
IgM Memory B Cells Are Reduced in the Blood of Splenecto-
mized and Asplenic Patients.
 
We compared the frequency
of B cells in the blood of normal donors and of 14 patients
splenectomized 6 mo to 9 yr before. There was a highly
significant difference in the frequency of memory B cells
(P 
 
  
 
0.001; Cochran-Cox 
 
t
 
 test) between the two groups.
Memory B cells were 45.9% (SD 
 
  
 
12.5) of the B cells in
the control group but were strongly reduced (7.1%, SD 
 
 
 
2.2) in the patients. IgM and switched memory B cells
were equally reduced in all patients independently of the
cause of splenectomy (Fig. 2 A). None of the patients suf-
fered from ongoing bacterial infections or were under
treatment at the time of analysis.
Congenital asplenia is a rare malformation associated to
life-threatening infections with encapsulated bacteria (2).
We compared peripheral blood B cells of a 62-yr-old
woman with congenital asplenia (11) with a splenecto-
mized patient with a normal control. The splenectomized
patient had a low frequency of both IgM and switched
memory B cells. In contrast, only IgM memory B cells
were undetectable in the blood of the congenitally asplenic
patient and switched memory B cells were present at nor-
mal frequency (Fig. 2 B). Because switched memory B cells
were also found in a patient splenectomized 40 yr before,
the spleen is indispensable for the generation or survival of
Figure 2. (A) Frequency of IgM and switched memory B cells in 11 controls and 14 splenectomized patients. (B) PBLs from the indicated subjects
were stained and analyzed as described in Fig. 1 A. On the top, the expression of CD22 and CD27 is shown. The numbers indicate the frequency of
memory B cells, calculated as a percentage of CD22  B cells. On the bottom, IgM and switched memory B cells were identified as described in Fig. 1 A.T
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IgM memory B cells whereas switched memory B cells can
also develop in other lymphoid tissues.
 
The Presence of IgM Memory B Cells in the Blood Correlates
with Protection from Pneumococcal Infections.
 
The asplenic
patient had suffered from recurrent respiratory tract and
middle ear infections all her life and was hospitalized for
overwhelming septicemia caused by 
 
S. pneumoniae 
 
(11) 2 yr
before our analysis. The patient splenectomized 40 yr be-
fore also had recurrent pneumococcal infections. The clini-
cal history of these patients confirms the association be-
tween absence of the spleen and recurrent infections. The
lack of IgM memory but not of switched memory B cells
suggests a protective role of IgM memory B cells against
pneumococcal infections.
We also analyzed the blood of a 56-yr-old patient
thought to be asplenic because of thrombocytosis and pres-
ence of Howell-Jolly bodies (12) but without history of re-
current infections. In the peripheral blood, memory B cells
were found. 77% of them were switched and only 23%
were IgM memory (Fig. 2 B, vestigial spleen). Ectopic
spleen has been described (13). In this patient, accurate
studies revealed an ectopic vestigial spleen, which was not
sufficient to fulfil its physiological function of removing
Howell-Jolly bodies and sequestering platelets from the
blood but efficiently supported the generation and/or sur-
vival of IgM memory B cells. The presence of these cells
was correlated with the lack of recurrent and chronic infec-
tions in this patient.
 
IgM Memory B Cells Are Undetectable in Infants. Their Fre-
quency Correlates with the Level of Antipneumococcal Polysaccha-
rides IgM.
 
To confirm the association between IgM
memory B cells and susceptibility to 
 
S. pneumoniae
 
, we ana-
lyzed B cell populations in the peripheral blood of infants,
which represent a group with a high risk of infection (4).
We analyzed B cell populations in 39 healthy children of
different ages (0–7 yr). We found that memory B cells were
undetectable in cord blood, slowly increased during the
first year of life, and reached 10–20% of the B cells at 2 yr.
Higher frequencies were found in older children and adults
(Fig. 3 A). In young children 
 
 
 
99% of CD27
 
  
 
B cells were
IgM memory B cells.
Natural antibodies make up most of the IgM in the se-
rum and have the function to limit the growth and dissem-
ination of pathogens during the early phases of infection
and potentiate the acquired immune response (14). In the
mouse they are produced by B-1a B cells (15).
Figure 3. (A) Frequency of memory B
cells in children. PBLs from 0–7-yr-old
healthy children were stained and analyzed
as described in Fig. 1 A. The frequency of
CD22  CD27  memory B cells as a per-
centage of total CD22  B cells is shown.
The age in months is indicated on the x
axis. (B) The level of total IgM in eight
children of different ages and in one adult
control were measured by ELISA and com-
pared with the concentration of IgM spe-
cific for pneumococcal polysaccharide sero-
type 22. Total IgM is indicated by   (scale
on the right y axis in micrograms/ml) and
polysaccharide-specific IgM is indicated by
the columns (scale in OD on the left y axis).
The age in months is shown on the x axis.
(C) Flow cytometric analysis of PBL from
three asplenic and three control children.
Samples were stained and analyzed as de-
scribed in Fig. 1 A. The density plots show
the CD22 and CD27 distribution. The fre-
quency of memory B cells (as a percentage
of total B cells) and the age of the children
are indicated.T
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We measured the levels of IgM binding pneumococcal
polysaccharides of 3, 9, and 22 serotypes in the serum of
children. Antibodies were undetectable at birth and pro-
gressively increased. There was a statistically significant cor-
relation between the level of polysaccharide-binding serum
IgM and age (P 
 
  
 
0.0001) and between the level of specific
antibodies and IgM memory B cells in the blood (P 
 
 
 
0.0001). 2-yr-old children had the same amount of polysac-
charide-specific antibodies as adults. Because adult levels of
total IgM were reached earlier, by 7–8 mo of age (Fig. 3 B),
polysaccharide-specific IgM is produced relatively late.
Our data shows that in infants the absence of IgM mem-
ory B cells is associated with a low level of polysaccharide-
specific IgM. During the second year of life children have a
reduced risk of pneumococcal infections and are able to re-
spond to polysaccharide vaccines. At this time they have
about half of the memory B cells of the adult and the same
amount of polysaccharide-specific IgM.
The age-related development of IgM memory B cells
does not occur in children with congenital asplenia, as
shown by the analysis of three asplenic children (Fig. 3 C).
A reduction of the memory B cell pool could be seen in
the two older children. IgM memory B cells were unde-
tectable and all CD27
 
  
 
B cells were switched memory. In
contrast, changes in the frequency of memory B cells were
not evident in the youngest child because this population is
also rare in healthy controls at this age. These data confirm
the correlation between the presence of the spleen and IgM
memory B cells in the blood.
 
IgM Memory B Cells in Asymptomatic CVID Patients.
 
Systemic respiratory infections by encapsulated bacteria are
the most important clinical manifestation leading to perma-
nent organ damage and eventually death in CVID (16).
Surprisingly, despite the profound hypogammaglobuline-
mia, some CVID patients have no infections.
To investigate whether the different susceptibility to in-
fections was correlated to a defined B cell defect, we ana-
lyzed the B cell compartment in patients with or without re-
current infections. All patients had a normal frequency of B
cells and a functional spleen, but those with infections lacked
IgM memory B cells whereas those who did not have infec-
tions had a normal frequency of IgM memory B cells (Table
I). IgM memory B cells, therefore, are the B cell subset in-
dispensable for the protection against encapsulated bacteria.
 
Discussion
 
We have recently shown that in mice the spleen is indis-
pensable for the generation or survival of B-1a B cells (17).
B-1a B cells are the major source of natural antibodies and
rapidly produce Igs in response to encapsulated bacteria
(15). Mice lacking B-1a B cells have a low level of natural
IgM and do not produce antibodies in response to pneu-
mococcal polysaccharide vaccines.
We now demonstrate that in humans the so-called IgM
memory B cells have similar survival requirements and
function as murine B-1a B cells. Similarly to B-1a B cells,
IgM memory B cells cannot be detected in splenectomized
and asplenic individuals and their absence is associated with
an increased frequency of pneumococcal infections and im-
paired response to polysaccharide vaccines.
Memory B cells are classically described as highly specific
and long-lived cells, generated in response to infectious
agents or vaccines in the germinal centers after somatic mu-
tation, selection, and class switch (18). They persist in the
organism and rapidly produce antibodies upon a second
challenge with the same pathogen.
In humans 30–60% of the B cells express CD27 and are
considered memory B cells. Half of them are IgM memory
and the rest are switched memory B cells. IgM memory B
cells have few somatic mutations and switched memory B
cells express highly mutated V
 
H 
 
sequences (9).
Our data suggest that IgM memory B cells have different
origins and functions from switched memory B cells. They
are undetectable in splenectomized and asplenic patients. In
contrast, switched memory B cells are only transiently de-
pleted after splenectomy and are present at normal frequen-
cies in asplenic patients. Because IgM memory B cells car-
rying somatic mutations can be detected in patients with
X-linked HyperIgM syndrome, it has been suggested that
only switched but not IgM memory B cells originate from
the germinal centers (19). IgM memory B cells, therefore,
may originate in the spleen, in extrafollicular sites, and in-
dependently of T cells. Because switched memory B cells
only derive from the germinal centers, they represent the
“true” memory pool.
Infections of the respiratory tract by encapsulated bacte-
ria remain localized and might be asymptomatic in normal
individuals. They are far more frequent, severe, and inva-
sive in patients with anatomical or functional asplenia. The
spleen has the function of entrapping circulating pathogens
during systemic infections. Our data suggest that it also
plays a fundamental role in preventing the spreading of lo-
 
Table I.
 
Frequency of B Cells, Memory B Cells, and IgM 
Memory B Cells in CVID Patients
 
Patients
Age
(years)
Percent
B cells
Percent
CD27
 
 
 
B cells
Percent
IgM memory
Infections by
encapsulated
bacteria
1 24 8.7 2.12 undetectable yes
2 20 17.1 3.5 undetectable yes
3 27 7.2 3.3 undetectable yes
4 32 14.92 8 94.5 no
5
 
a
 
43 8.4 72.7 88.8 no
6
 
a
 
51 11.9 53 85.4 no
All patients were diagnosed as having CVID and received intravenous
Ig treatment. Percent of B cells was calculated in the lymphocyte gate,
percent of CD27
 
  
 
B cells was calculated considering B cells as 100%
positive, and percent of IgM memory B cells was calculated considering
the CD27
 
  
 
B cells as 100%.
 
a
 
These patients have a major T cell defect.T
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calized infection by the generation of IgM memory B cells.
This is supported by the observation that localized infec-
tions are more frequent and often develop into invasive
diseases (e.g., pulmonitis, meningitis) in individuals lacking
IgM memory B cells but with an intact spleen, such as
young children and CVID patients. OPSI never occurs in
these cases, underlining that splenic components other than
B cells remove circulating bacteria and avoid systemic in-
fections that become overwhelming.
The traditional vaccine against 
 
S. pneumoniae
 
, which
contains a mixture of capsular polysaccharides from the 23
most frequent bacterial serotypes, induces antibody pro-
duction only if administered before splenectomy, but is in-
effective if the spleen has been already removed (3). Simi-
larly, it is not protective in children before 2 yr of age.
Thus, IgM memory B cells produce antibodies in response
to bacterial polysaccharides.
Based on our data, IgM memory B cells functionally re-
semble murine B-1a B cells but do not express CD5 and
may have a different tissue distribution. The frequency of
CD5
 
  
 
B cells, which varies between donors, does not iden-
tify any B cell subset. Paradoxically, CD5
 
  
 
B cells are partic-
ularly frequent in young children (unpublished data), the age
group most susceptible to pneumococcal infections. Sple-
nectomy had no effect on the frequency of CD5
 
  
 
B cells.
Although CD5 may also have a relevant function in humans,
its expression cannot be used to identify human B-1a B cells.
The great majority of B-1a B cells is in the mouse peritoneal
cavity. We did not find IgM memory B cells in peritoneal
exudates (unpublished data). This could be explained by dif-
ferences in mouse and human anatomy, B cell recirculation,
and pathogen tropism. Accordingly, it has been shown that
CD5
 
  
 
B cells cannot be found in the peritoneal cavity of
rats, but rat fetal liver stem cells transplanted in mouse gener-
ate CD5
 
  
 
B cells, which populate the peritoneal cavity (20).
We show that circulating IgM memory B cells mirror
the presence of functional splenic tissue, albeit ectopic and
of small size, associated with a low risk of infection and
OPSI. Thus, detection of IgM memory B cells could be
used to discriminate between patients with a high or low
risk of infection after splenectomy and consequent degree
of a patient’s invalidism.
In children, polysaccharide protein conjugate vaccines
against 
 
S. Pneumoniae
 
 reduce the risk of systemic infection
Figure 4. Our model on the origin and function of mature and IgM memory B cells. IgM memory B cells might be able to migrate to sites of inflam-
mation and recognize invading pathogens through the B cell receptor (BCR) and possibly other pathogen-binding coreceptors. Switched memory B cells
are generated from bone marrow–derived mature B cells after somatic mutation and class switch in the germinal centers.T
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by 90%. By eliciting a classical T-dependent immune re-
sponse they bypass the immunological impairment due to
the lack of IgM memory B cells. The administration of
conjugate vaccines should therefore reduce the risk of sys-
temic disease and most likely OPSI after splenectomy.
We propose a model in which IgM and switched memory
B cells have different origins and functions. The spleen is in-
dispensable to ensure the presence of circulating IgM mem-
ory B cells. It is not known whether the spleen supports IgM
memory survival or is the site where IgM memory B cells
are generated. B-1a B cells, which are functionally homolo-
gous to IgM memory B cells, derive from fetal liver precur-
sors. IgM memory B cells produce natural antibodies and are
necessary for the T-independent response against encapsu-
lated bacteria. Mature B cells are generated in the bone mar-
row, populate spleen and lymph nodes, and in the germinal
centers give rise to switched memory B cells (Fig. 4).
Finally, because the first and most important sign of pri-
mary and secondary B cell immunodeficiency is a high in-
cidence of infections by encapsulated bacteria, the defense
against these pathogens might be the primary function of B
cells and we show that this function is performed by IgM
memory cells.
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